2023-08-15 08:41:43 ET
- Akari Therapeutics ( NASDAQ: AKTX ) said on Tuesday that it plans to change the ratio of its American Depositary Shares to ordinary shares from one ADS representing one hundred ordinary shares to a new ratio of one ADS representing two thousand ordinary shares.
-
The company said it intends to change the ADS ratio to a new ratio of 1:20.
-
The company said the ADS ratio change will be effective on August 17, 2023.
-
The change is intended to enable the company to regain compliance with the Nasdaq minimum bid price requirement.
For further details see:
Akari Therapeutics announces ADS ratio change